CD1-restricted NK T cells protect nonobese diabetic mice from developing diabetes.
about
NKT cells stimulated by long fatty acyl chain sulfatides significantly reduce the incidence of type 1 diabetes in nonobese diabetic mice [corrected]The Role of Invariant Natural Killer T Cells in Dendritic Cell Licensing, Cross-Priming, and Memory CD8(+) T Cell GenerationiNKT and MAIT Cell Alterations in DiabetesDendritic cell subsets in type 1 diabetes: friend or foe?Double negative (CD3+ 4- 8-) TCR alphabeta splenic cells from young NOD mice provide long-lasting protection against type 1 diabetesUnraveling the Hygiene Hypothesis of helminthes and autoimmunity: origins, pathophysiology, and clinical applicationsCritical proinflammatory and anti-inflammatory functions of different subsets of CD1d-restricted natural killer T cells during Trypanosoma cruzi infection.Innate-like control of human iNKT cell autoreactivity via the hypervariable CDR3beta loop.Distinct requirements for CD1d intracellular transport for development of V(alpha)14 iNKT cells.Modulation of CD1d-restricted NKT cell responses by using N-acyl variants of alpha-galactosylceramides.Glycolipid antigen induces long-term natural killer T cell anergy in mice.Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets.Development of spontaneous anergy in invariant natural killer T cells in a mouse model of dyslipidemia.Disposal of iNKT cell deficiency and an increase in expression of SLAM signaling factors characterizes sarcoidosis remission: a 4-year longitudinal study.NKT Cell Subsets Can Exert Opposing Effects in Autoimmunity, Tumor Surveillance and InflammationNonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis.NKT cell stimulation with glycolipid antigen in vivo: costimulation-dependent expansion, Bim-dependent contraction, and hyporesponsiveness to further antigenic challenge.Clinical application of NKT cell assays to the prediction of type 1 diabetes.The enemy within: keeping self-reactive T cells at bay in the periphery.NKT cells: potential targets for autoimmune disease therapy?Innate immunity and primary biliary cirrhosis: activated invariant natural killer T cells exacerbate murine autoimmune cholangitis and fibrosisInnate self recognition by an invariant, rearranged T-cell receptor and its immune consequences.Understanding the function of CD1-restricted T cells.Potential role of IL-17-producing iNKT cells in type 1 diabetes.A locus on mouse chromosome 13 inversely regulates CD1d expression and the development of invariant natural killer T-cells.The split personality of NKT cells in malignancy, autoimmune and allergic disordersType 1 diabetes and NKT cells: a report on the 3rd International Workshop on NKT cells and CD1-mediated antigen presentation, September 2004, Heron Island, QLD, AustraliaGenetic control of murine invariant natural killer T-cell development dynamically differs dependent on the examined tissue type.CD1d-restricted T-cell subsets and dendritic cell function in autoimmunity.Natural killer T cells as targets for immunotherapy of autoimmune diseases.Going both ways: immune regulation via CD1d-dependent NKT cells.alpha-Galactosylceramide therapy for autoimmune diseases: prospects and obstacles.Regulatory T cells in the control of autoimmune diabetes: the case of the NOD mouse.Activation of natural killer T cells in NZB/W mice induces Th1-type immune responses exacerbating lupusStructural features of the acyl chain determine self-phospholipid antigen recognition by a CD1d-restricted invariant NKT (iNKT) cellInnovative immune-based therapeutic approaches for the treatment of type 1 diabetes mellitus.The natural killer T lymphocyte: a player in the complex regulation of autoimmune diabetes in non-obese diabetic mice.Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis.Activation of natural killer T cells potentiates or prevents experimental autoimmune encephalomyelitis.A natural killer T (NKT) cell developmental pathway iInvolving a thymus-dependent NK1.1(-)CD4(+) CD1d-dependent precursor stage.
P2860
Q21134826-72877B38-C960-4BEC-893A-24FE7C06C928Q26797344-59D944B2-E0C0-4D2F-83FD-4923D37F1F9EQ26801962-DB751648-C8CA-4DA6-BA56-C54BFB99E11DQ26866500-AE05D423-6481-4553-AED7-41B9E0567E0CQ27324275-8CD29836-378C-4024-B933-E6BE9CEC0D27Q28082281-B2794237-B203-4B2F-BAD9-A3F7248AB7F8Q33558006-F0838FA1-7CAC-4B9A-A6C0-EDB66285F732Q33618864-BB8719D1-6DAE-4E6B-BCCE-01B8390D35D6Q33731430-069D2B69-8E50-4132-BCD3-25BB357585CAQ33927443-7D0FBB5F-C806-4F04-B46E-F64F709ED201Q33930869-6D0F2D01-F74A-4BC3-8BEF-C13B4C8270B5Q33950117-301A595C-26DF-41F5-AA9E-4B73A1667FC9Q34235221-400A29ED-8146-416C-A0C2-E780386A4260Q34270878-9FD9EC39-FA38-4E74-A111-EFB60B59E655Q34288977-35D21641-9D6B-40D7-8593-BE7C7C4A3C82Q34321127-EA8B76BC-2077-44B5-A3C4-E8BFD8EDBAFEQ34333607-0F540F08-AB3B-425A-8C9E-63FEAE50DCE1Q34470637-C2EF77C1-3205-424A-88F3-41F0A9D6EDE0Q34573771-E60B5CBC-853D-4C98-9D11-DD2DEDFAFA98Q34764715-70338802-5E0C-4C6D-9598-6368CF51318DQ34790985-F94B6750-E94C-4F75-A75A-6A9177A09DFBQ35131643-8BC2CB6B-C812-4D77-B3F7-A7B873D314C3Q35139857-1246B0F2-2FFB-4526-AA39-2914ADC1E352Q35161591-945D6E36-7052-4CFE-A46E-4D9B259FC591Q35537082-DDB7B88C-59B9-4803-8388-01917229F734Q35590727-3CDA1BEF-9858-4FDF-B35C-287BD5F2CA8EQ35612660-F4D1F57F-A100-4F06-AECD-040A956340C9Q35795122-2A186407-6337-44D3-BBFF-598DFD7DA0F0Q35798159-1284760A-20FE-49ED-A76B-26FF5C2D371BQ35798168-21BFC419-89D5-42FA-93BF-AC2C0A3B75C8Q35951531-B6FDDC81-B162-4378-846E-95A9AE842E1BQ35998799-F5792FF2-F609-4396-A776-A77FF453A479Q36203572-C5F3AFDE-6960-4BFE-A90C-DF0B6ED0A5EBQ36259479-5E61E5CC-9F94-4AD4-ABFC-5032A87B0135Q36300615-66BEB03F-9C57-46F7-86FD-D59B5FEA6264Q36327358-D0279AD2-AF76-4D0F-A9D3-AB9287DDBF58Q36367836-DF2A475E-9B87-4FCB-83E0-960D12E366DBQ36369797-248F8E60-640E-4E6D-B90C-B6C6A0745AB3Q36369830-8789275B-DD66-47F9-9D29-66C90221A9CCQ36370202-1DA4B758-7305-4653-A514-6795EA4D3922
P2860
CD1-restricted NK T cells protect nonobese diabetic mice from developing diabetes.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
CD1-restricted NK T cells protect nonobese diabetic mice from developing diabetes.
@ast
CD1-restricted NK T cells protect nonobese diabetic mice from developing diabetes.
@en
type
label
CD1-restricted NK T cells protect nonobese diabetic mice from developing diabetes.
@ast
CD1-restricted NK T cells protect nonobese diabetic mice from developing diabetes.
@en
prefLabel
CD1-restricted NK T cells protect nonobese diabetic mice from developing diabetes.
@ast
CD1-restricted NK T cells protect nonobese diabetic mice from developing diabetes.
@en
P2093
P2860
P356
P1476
CD1-restricted NK T cells protect nonobese diabetic mice from developing diabetes.
@en
P2093
P2860
P304
P356
10.1084/JEM.194.3.313
P407
P577
2001-08-01T00:00:00Z